Developer docs
API playgroundTry for free, no card

Search company profiles

Iris Biotech

Full company profile

uuid000l31s

Namestring
Iris Biotech
Legal namestring
Iris Biotech GmbH
Websiteurl
iris-biotech.de
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Iris Biotech GmbH is a privately held German specialty chemicals supplier founded in 2001 and headquartered in Marktredwitz, Bavaria. The company focuses on chemical reagents and building blocks used in peptide synthesis, PEGylation, and adjacent life science research workflows, serving academic institutions, pharmaceutical and biotechnology R&D groups, peptide synthesis service providers, and contract manufacturing organizations. Its customer base spans pharmaceutical drug discovery, bioconjugation chemistry (including ADC development), and formulation research.

The core product platform is organized into ten catalog categories totaling more than 5,873 SKUs, anchored by over 3,188 amino acids (Fmoc, Boc, and proprietary Smoc protected variants), approximately 1,000 resins for solid-phase synthesis, 898 drug delivery materials (PEGs, poly-amino acids, poly(2-oxazolines), dextrans, lipids, nanoparticles), 588 click chemistry products, and 465 building blocks. Proprietary technology includes the Linkerology® trademarked family of cleavable, photo-activatable, and trifunctional linkers for bioconjugation; Smoc (2,7-Disulfo-9-fluorenylmethoxycarbonyl) protected amino acids enabling water-compatible synthesis with intrinsic fluorescence; and CliCr® strained-alkyne (TMTHSI) reagents for site-specific peptide functionalization. A dedicated Green Chemistry line and a Custom Synthesis service extend the offering beyond the standard catalog.

Iris Biotech operates a B2B sales-led go-to-market built on a direct e-commerce storefront at iris-biotech.de with multi-currency checkout (EUR, USD), complemented by regional distribution partners. Pricing is unit-based, varies by product complexity and quantity, and revenue is generated primarily through one-time catalog purchases of milligram-to-gram quantities. Knowledge base content, workshop series, and downloadable scientific publications support demand generation. Revenue is not publicly disclosed, and the company has no disclosed outside funding, acquisitions, or parent ownership.

Short descriptiontext

Iris Biotech GmbH is a German specialty chemicals supplier founded in 2001, providing more than 5,800 reagents and building blocks for peptide synthesis, PEGylation, bioconjugation, and drug delivery to pharma, biotech, and academic research customers worldwide via e-commerce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMarktredwitz, Germany
HQ citystring
Marktredwitz
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotech reagents, peptide synthesis, life science chemicals, biopharmaceutical supplies, chemical manufacturing
Product category
Biotechnology Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Chemical Reagent Product Sales
TypeOne Time License
Description

Sale of specialized chemical reagents including amino acids, building blocks, linkers, resins, click chemistry products, and drug delivery materials. Products sold in various quantities (mg, g units) with pricing based on complexity and quantity.

iris-biotech.de
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Pricing details1 tier
1Unit-based pricing for chemical reagents
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products priced per unit (100mg, 250mg, 1g, etc.). Example prices: NTCB RL-4080 at €240/g, Fmoc-L-Ala-OH at €30, Biotin-Aca-PFP from €45/100mg. Custom synthesis quotes available on request.

iris-biotech.de
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Based on the company name alone, no source-supported description of the core offering is available in the input.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Iris Biotech is a supplier of chemical reagents and building blocks for peptide synthesis and related life science applications. The company operates a single e-commerce platform offering multiple product categories that serve as complementary components of the peptide synthesis workflow. The core portfolio consists of: Amino Acids (over 3,188 products) as fundamental building blocks; Linkerology® branded linkers for bioconjugation; Resins (about 1,000 products) for solid phase synthesis; Click Chemistry (588 products) for in vitro/in vivo applications; Building Blocks (465 products); Drug Delivery (898 products) including PEGs and nanoparticles; Reagents; and Life Sciences products. The company also offers Custom Synthesis services for custom compounds and a dedicated Green Chemistry line for sustainable synthesis. The product ecosystem is tied together by a Knowledge Base providing SDF files, FAQs, publications, and workshop resources.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Regional distribution partners that extend Iris Biotech's market reach in specific geographic areas. Partners resell the company's chemical reagent products to end customers in their respective regions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AnaSpec, now part of Kaneka, supplies specialty peptides, amino acids, and detection reagents to life science researchers. Product categories and customer base closely mirror Iris Biotech's reagent business.

TypeDirect peer
Description

Polypeptide Group is a peptide CDMO producing peptide APIs and associated intermediates. It shares Iris Biotech's CMO customer segment and overlap in protected amino acids and peptide synthesis building blocks.

TypeBroad incumbent
Description

Thermo Fisher, through its Life Sciences portfolio including Pierce and Acetyl/Methylation reagents, sells into peptide and life science research customers. It competes broadly as an incumbent with deeper regulatory and logistics infrastructure than Iris Biotech.

TypeDirect peer
Description

GenScript offers custom peptide synthesis, peptide libraries, and a broad life science reagent catalog. It competes directly for custom synthesis orders and research-grade reagent demand served by Iris Biotech.

TypeDirect peer
Description

ChemPep specializes in custom peptide synthesis and specialty amino acids for the biotech and pharma research markets. It is a smaller, directly comparable competitor with overlapping reagent and custom synthesis offering.

TypeDirect peer
Description

Bio-Synthesis provides custom peptide synthesis, peptide libraries, and bioconjugation reagents. Comparable to Iris Biotech in custom synthesis capabilities and research-grade reagent offering.

TypeDirect peer
Description

Bachem is a leading peptide and oligonucleotide CDMO with deep expertise in protected amino acids and peptide synthesis reagents, serving pharma and biotech. It directly overlaps with Iris Biotech's protected-amino-acid core and CMO-customer strategy.

8Peptide Institute, Inc.
TypeDirect peer
Description

Peptide Institute is a Japanese specialist in synthetic peptides, protected amino acids, and peptide-related reagents. Comparable scope in protected amino acids, resins, and custom peptide synthesis with similar research and biopharma customers.

TypeDirect peer
Description

CPC Scientific focuses on custom peptide synthesis, amino acid derivatives, and bioconjugation services. It is a direct overlap with Iris Biotech's amino acid, custom synthesis, and linker product lines.

10Merck KGaA (MilliporeSigma / Novabiochem)
TypeBroad incumbent
Description

MilliporeSigma operates Novabiochem, the established flagship brand for peptide synthesis reagents, protected amino acids, and resins. It is the dominant incumbent against whose pricing Iris Biotech competes for the same research customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Iris Biotech

Biotechnology Reagentsiris-biotech.de

Iris Biotech GmbH is a German specialty chemicals supplier founded in 2001, providing more than 5,800 reagents and building blocks for peptide synthesis, PEGylation, bioconjugation, and drug delivery to pharma, biotech, and academic research customers worldwide via e-commerce.

What Iris Biotech does

Iris Biotech GmbH is a privately held German specialty chemicals supplier founded in 2001 and headquartered in Marktredwitz, Bavaria. The company focuses on chemical reagents and building blocks used in peptide synthesis, PEGylation, and adjacent life science research workflows, serving academic institutions, pharmaceutical and biotechnology R&D groups, peptide synthesis service providers, and contract manufacturing organizations. Its customer base spans pharmaceutical drug discovery, bioconjugation chemistry (including ADC development), and formulation research.

The core product platform is organized into ten catalog categories totaling more than 5,873 SKUs, anchored by over 3,188 amino acids (Fmoc, Boc, and proprietary Smoc protected variants), approximately 1,000 resins for solid-phase synthesis, 898 drug delivery materials (PEGs, poly-amino acids, poly(2-oxazolines), dextrans, lipids, nanoparticles), 588 click chemistry products, and 465 building blocks. Proprietary technology includes the Linkerology® trademarked family of cleavable, photo-activatable, and trifunctional linkers for bioconjugation; Smoc (2,7-Disulfo-9-fluorenylmethoxycarbonyl) protected amino acids enabling water-compatible synthesis with intrinsic fluorescence; and CliCr® strained-alkyne (TMTHSI) reagents for site-specific peptide functionalization. A dedicated Green Chemistry line and a Custom Synthesis service extend the offering beyond the standard catalog.

Iris Biotech operates a B2B sales-led go-to-market built on a direct e-commerce storefront at iris-biotech.de with multi-currency checkout (EUR, USD), complemented by regional distribution partners. Pricing is unit-based, varies by product complexity and quantity, and revenue is generated primarily through one-time catalog purchases of milligram-to-gram quantities. Knowledge base content, workshop series, and downloadable scientific publications support demand generation. Revenue is not publicly disclosed, and the company has no disclosed outside funding, acquisitions, or parent ownership.

Iris Biotech firmographics

Firmographics
Name
Iris Biotech
Legal name
Iris Biotech GmbH
Website
https://iris-biotech.de
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
Iris Biotech GmbH is a German specialty chemicals supplier founded in 2001, providing more than 5,800 reagents and building blocks for peptide synthesis, PEGylation, bioconjugation, and drug delivery to pharma, biotech, and academic research customers worldwide via e-commerce.
Ownership category
akta.pro rank

Where Iris Biotech is headquartered

Location

Headquarters

HQ city
Marktredwitz
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Iris Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Revenue model

  1. Chemical Reagent Product Sales: Sale of specialized chemical reagents including amino acids, building blocks, linkers, resins, click chemistry products, and drug delivery materials. Products sold in various quantities (mg, g units) with pricing based on complexity and quantity.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goUnit-based pricing for chemical reagents

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Iris Biotech product offering

Product offering

Core offering

Based on the company name alone, no source-supported description of the core offering is available in the input.

Product overview

Iris Biotech is a supplier of chemical reagents and building blocks for peptide synthesis and related life science applications. The company operates a single e-commerce platform offering multiple product categories that serve as complementary components of the peptide synthesis workflow. The core portfolio consists of: Amino Acids (over 3,188 products) as fundamental building blocks; Linkerology® branded linkers for bioconjugation; Resins (about 1,000 products) for solid phase synthesis; Click Chemistry (588 products) for in vitro/in vivo applications; Building Blocks (465 products); Drug Delivery (898 products) including PEGs and nanoparticles; Reagents; and Life Sciences products. The company also offers Custom Synthesis services for custom compounds and a dedicated Green Chemistry line for sustainable synthesis. The product ecosystem is tied together by a Knowledge Base providing SDF files, FAQs, publications, and workshop resources.

Differentiator

Problem solved

Functional benefit

Companies that use Iris Biotech

Customer profile

Segments3 records

Iris Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Iris Biotech partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Distribution PartnerssupportingChannel Partner/ Reseller/ DistributorRegional distribution partners that extend Iris Biotech's market reach in specific geographic areas. Partners resell the company's chemical reagent products to end customers in their respective regions.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Iris Biotech competitors and assessment

Company assessment

Direct peers

  • AnaSpec (Kaneka): AnaSpec, now part of Kaneka, supplies specialty peptides, amino acids, and detection reagents to life science researchers. Product categories and customer base closely mirror Iris Biotech's reagent business.
  • Polypeptide Group: Polypeptide Group is a peptide CDMO producing peptide APIs and associated intermediates. It shares Iris Biotech's CMO customer segment and overlap in protected amino acids and peptide synthesis building blocks.
  • GenScript: GenScript offers custom peptide synthesis, peptide libraries, and a broad life science reagent catalog. It competes directly for custom synthesis orders and research-grade reagent demand served by Iris Biotech.
  • ChemPep Inc. ChemPep specializes in custom peptide synthesis and specialty amino acids for the biotech and pharma research markets. It is a smaller, directly comparable competitor with overlapping reagent and custom synthesis offering.
  • Bio-Synthesis Inc. Bio-Synthesis provides custom peptide synthesis, peptide libraries, and bioconjugation reagents. Comparable to Iris Biotech in custom synthesis capabilities and research-grade reagent offering.
  • Bachem: Bachem is a leading peptide and oligonucleotide CDMO with deep expertise in protected amino acids and peptide synthesis reagents, serving pharma and biotech. It directly overlaps with Iris Biotech's protected-amino-acid core and CMO-customer strategy.
  • Peptide Institute, Inc. Peptide Institute is a Japanese specialist in synthetic peptides, protected amino acids, and peptide-related reagents. Comparable scope in protected amino acids, resins, and custom peptide synthesis with similar research and biopharma customers.
  • CPC Scientific: CPC Scientific focuses on custom peptide synthesis, amino acid derivatives, and bioconjugation services. It is a direct overlap with Iris Biotech's amino acid, custom synthesis, and linker product lines.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher, through its Life Sciences portfolio including Pierce and Acetyl/Methylation reagents, sells into peptide and life science research customers. It competes broadly as an incumbent with deeper regulatory and logistics infrastructure than Iris Biotech.
  • Merck KGaA (MilliporeSigma / Novabiochem): MilliporeSigma operates Novabiochem, the established flagship brand for peptide synthesis reagents, protected amino acids, and resins. It is the dominant incumbent against whose pricing Iris Biotech competes for the same research customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Iris Biotech social profiles

Digital presence

Iris Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Iris Biotech leadership team

Management profile

Number of profiles

Iris Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Iris Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iris Biotech

What does Iris Biotech do?

Based on the company name alone, no source-supported description of the core offering is available in the input.

Is Iris Biotech a public or private company?

Iris Biotech is a private company. It is classified as unknown and is currently operating.

When was Iris Biotech founded?

Iris Biotech was founded in 2001. It employs 11 to 50 people.

Where is Iris Biotech based?

Iris Biotech is headquartered in Marktredwitz, Germany, in the Europe region.

How does Iris Biotech make money?

One revenue line is on record: chemical Reagent Product Sales.

Who are Iris Biotech's main competitors?

Direct peers on record are AnaSpec (Kaneka), Polypeptide Group, GenScript, ChemPep Inc., Bio-Synthesis Inc., Bachem, Peptide Institute, Inc. and CPC Scientific. Broad incumbents are Thermo Fisher Scientific and Merck KGaA (MilliporeSigma / Novabiochem).

Does Iris Biotech have an API?

No public API is recorded for Iris Biotech.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals